Search all trials

Find therapies in clinical trials near you – page 21

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Not recruiting

Registered drug

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Dextrose Bp

Contact Research Centre

Anxiety disorder

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to SSRI, Clomipramine, Venlafaxine, or Desvenlafaxine

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Troriluzole

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

IgA nephropathy

Not recruiting

Registered drug

Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Ravulizumab

Contact Research Centre

Hypercholesterolaemia

Not recruiting

Registered drug

Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Inclisiran

Contact Research Centre

Pseudomonas infection

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Amikacin

Contact Research Centre

Acute myeloid leukaemia recurrent

Not recruiting

InvestigationalNo placebo

Study of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ziftomenib

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis

Registered drug

Spain

Participants:0–17 years
Substances:Ofatumumab

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Find therapies in clinical trials near you – page 21

310 trials match your criteria

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Anxiety disorder

Long-Term Safety Study of Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to SSRI, Clomipramine, Venlafaxine, or Desvenlafaxine

Non-small cell lung cancer

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Plasma cell myeloma refractory

Study Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments

IgA nephropathy

Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

Hypercholesterolaemia

Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

Pseudomonas infection

Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

Acute myeloid leukaemia recurrent

Study of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Multiple sclerosis

Study on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis

Breast cancer

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Hepatocellular carcinoma

Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

Gastroenteropancreatic neuroendocrine tumour disease

Study of Lutetium (177Lu) Edotreotide compared to standard treatment in patients with aggressive Grade 2 and Grade 3 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.